Back to search

Article

Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancer

2022-12-07

Abstract excerpt

<h4>Background: </h4> The host immune system affects treatment response to immune checkpoint inhibitors (ICIs) and can be reflected by circulating immune cells. The aims of this study were to evaluate whether circulating T cells are correlated with clinical response and dermatologic toxicities in patients with advanced gastric and esophageal cancer receiving PD-1 inhibitor-based combination therapy. Methods Patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7cec1a23-ae6a-5c6d-84cf-97d2d5af4452
DOI
10.21203/rs.3.rs-2345882/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancerDOI 10.21203/rs.3.rs-2345882/v1
Prediction and treatment of skin adverse reactions related to inhibitors at immune checkpointsSemantic proximity
Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical SettingSemantic proximity
Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity
Identification and validation of a novel survival prediction model based on the T cell phenotype in tumor immune microenvironment and peripheral blood for the prognosis in gastric cancerSemantic proximity
Association of Blood Biomarkers and Autoimmunity with Immune Related Adverse Events in Patients with Cancer treated with Immune Checkpoint InhibitorsSemantic proximity
PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity
Characterization of the Different Subtypes of Immune Cells Infiltration to Aid ImmunotherapySemantic proximity
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors.Semantic proximity
Large-Scale Meta-Analysis of Potential Biomarkers for Treatment Response to Anti-PD-1/PD-L1 Immune Checkpoint InhibitorsSemantic proximity
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifierSemantic proximity
PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity.Semantic proximity
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, other than Abscopal Effect: A Systematic ReviewSemantic proximity
Select a neighboring publication to make it the new centre.